<DOC>
	<DOC>NCT00558597</DOC>
	<brief_summary>In patients with acute rejection after lung transplantation the peptide profile in broncho-alveolar lavage (BAL) and urine should be compared in order to identify a paradigm that allows an non-invasive rejection therapy.</brief_summary>
	<brief_title>Proteomics Analysis for Recognition of Acute Cellular Rejection After Lung Transplantation</brief_title>
	<detailed_description>Goal of the study is the establishment of biomarkers for early diagnosis of acute rejection, followed by a late validation of the paradigm with prospectively collected samples, which will be examined blinded.</detailed_description>
	<criteria>Patients with stable graft function Patients with acute rejection Acute infection BOS</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2008</verification_date>
	<keyword>Proteomics</keyword>
	<keyword>Lung Transplantation</keyword>
</DOC>